Orion is a globally operating Finnish company that develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company employs more than 3,000 professionals in different countries.
Established in 1917 in Finland, Orion now has sales companies and representative offices in more than 20 countries in Europe as well as in India and China. The company's head office is established in Espoo, Finland. The country is also home for the majority of Orion's production.
Outside Europe, our partners play a key role in the sale and marketing of the company's products. These important markets include the United States, the Latin America, Middle East and North Africa as well as Asia Pacific. In R&D, Orion has built an international network of best-in-class partners around its core therapy areas. Partnerships are also a key component of the company's supply chain.
Orion's A and B shares are listed on NASDAQ OMX Helsinki. To find out more about Orion, visit our main corporate website.